Rule: 6A-6.0252 Prev   Up   Next

Rule Title: Use of Prescribed Pancreatic Enzyme Supplements
Department: DEPARTMENT OF EDUCATION    Add to MyFLRules Favorites
Add to MyFLRules Favorites
Division: State Board of Education
Chapter: SPECIAL PROGRAMS I

Latest version of the final adopted rule presented in Florida Administrative Code (FAC):

VIEW_RULE Effective Date: 7/22/2014
History Notes: Rulemaking Authority 1002.20(3)(k) FS. Law Implemented 1002.20(3)(k), 1006.062(4) FS. History–New 5-5-13, Amended 7-22-14.
References in this version: No reference(s).
History of this Rule since Jan. 6, 2006
Notice /
Adopted
Section Description ID Publish
Date
View Text Final
6A-6.0252
Use of Prescribed Pancreatic Enzyme Supplements 14796688 Effective:
07/22/2014
View Text Correction
6A-6.0252
Use of Prescribed Pancreatic Enzyme Supplements 14602882 5/22/2014
Vol. 40/100
View Text Proposed
6A-6.0252
The purpose and effect of this rule amendment is to update the rule to reflect the new position statement by the National Association of School Nurses incorporated by reference rule 6A-6.0253, FAC. 14571939 5/20/2014
Vol. 40/98
View Text Development
6A-6.0252
The purpose and effect of this rule development is to update the rule to reflect the new position statement by the National Association of School Nurses incorporated by reference rule 6A-6.0253, FAC. The new position statement .... 14422559 4/8/2014
Vol. 40/68
View Text Final
6A-6.0252
Use of Prescribed Pancreatic Enzyme Supplements 12916246 Effective:
05/05/2013
View Text Change
6A-6.0252
Use of Prescribed Pancreatic Enzyme Supplements 12796063 3/22/2013
Vol. 39/57
View Text Proposed
6A-6.0252
The purpose and effect of this new rule is to address self-administration of pancreatic enzyme medication by students diagnosed with pancreatic insufficiency or cystic fibrosis enrolled in the public school system. 12625731 2/8/2013
Vol. 39/27
View Text Development
6A-6.0252
The purpose and effect of this rule development is to address self-administration of pancreatic enzyme medication by students diagnosed with pancreatic insufficiency or cystic fibrosis enrolled in the public school system..... 12398557 12/18/2012
Vol. 38/93
View Text Withdrawal
6A-6.0252
Use of Prescribed Pancreatic Enzyme Supplements 10906891 1/20/2012
Vol. 38/03
View Text Change
6A-6.0252
......
Use of Prescribed Pancreatic Enzyme Supplements, John M. McKay Scholarship for Students with Disabilities Program 10845975 1/6/2012
Vol. 38/01
View Text Proposed
6A-6.0252
The purpose of this new rule is to address self-administration of pancreatic enzyme medication by students diagnosed with pancreatic insufficiency or cystic fibrosis enrolled in the public school system. The effect will .... 10818621 12/22/2011
Vol. 37/51
View Text Development
6A-6.0252
The purpose and effect of this rule development is to address self-administration of pancreatic enzyme medication by students diagnosed with pancreatic insufficiency or cystic fibrosis enrolled in the public school system. .... 10536933 10/21/2011
Vol. 37/42